You are here: Controversies / Thomas A. Ban: Conflict of interest in neuropsychopharmacology / Comments by Barry Blackwell / Comment on Thomas Ban’s response to Barry Blackwell by Samuel Gershon
Tuesday, 28.03.2017

Comment on Thomas Ban’s response to Barry Blackwell by Samuel Gershon

Samuel Gershon’s comment on Thomas A. Ban’s response to Barry Blackwell’s response to Ban’s reply to Blackwell’s comment on Ban’s Conflict of Interest in Neuropsychopharmacology: Marketing vs. Education

I agree, but in addition, Pharma is in control of everything from telling the patient, based on information they give them about what medication to ask for. Then, when the doctor prescribes that drug, another force acting on the market, an ill-advised community advisory group, comes into force and gives ill advice, which is unhelpful.  I have been asked about 2 such cases in the last 10 days.

 

Samuel Gershon

February 26, 2015